These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29759142)

  • 1. Heterogeneity of auto-antibodies against nAChR in myasthenic serum and their pathogenic roles in experimental autoimmune myasthenia gravis.
    Nakamura R; Makino T; Hanada T; Terakawa M; Nagahira K; Yamate J; Shiraishi H; Motomura M
    J Neuroimmunol; 2018 Jul; 320():64-75. PubMed ID: 29759142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine receptor-specific immunosuppressive therapy of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Luo J; Lindstrom J
    Ann N Y Acad Sci; 2018 Feb; 1413(1):76-81. PubMed ID: 29377167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors.
    Luo J; Lindstrom J
    Autoimmunity; 2012 May; 45(3):245-52. PubMed ID: 21950318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches.
    Fuchs S; Aricha R; Reuveni D; Souroujon MC
    J Autoimmun; 2014 Nov; 54():51-9. PubMed ID: 24970384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats.
    Baggi F; Annoni A; Ubiali F; Milani M; Longhi R; Scaioli W; Cornelio F; Mantegazza R; Antozzi C
    J Immunol; 2004 Feb; 172(4):2697-703. PubMed ID: 14764745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice.
    Paas-Rozner M; Dayan M; Paas Y; Changeux JP; Wirguin I; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2168-73. PubMed ID: 10681457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The auto-antigen repertoire in myasthenia gravis.
    Vrolix K; Fraussen J; Molenaar PC; Losen M; Somers V; Stinissen P; De Baets MH; Martínez-Martínez P
    Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?
    Baggi F; Antozzi C; Toscani C; Cordiglieri C
    Arch Immunol Ther Exp (Warsz); 2012 Feb; 60(1):19-30. PubMed ID: 22159475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenogenicity of the main immunogenic region.
    Lindstrom J; Luo J
    Ann N Y Acad Sci; 2012 Dec; 1274(1):9-13. PubMed ID: 23252892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental autoimmune myasthenia gravis in the mouse.
    Wu B; Goluszko E; Huda R; Tüzün E; Christadoss P
    Curr Protoc Immunol; 2013; Chapter 15():Unit 15.8.. PubMed ID: 23392639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing Autoimmunity at the Synapse by a Novel Animal Model of Experimental Autoimmune Myasthenia Gravis.
    Wang J; Xiao Y; Zhang K; Luo B; Shen C
    Neuroscience; 2018 Mar; 374():264-270. PubMed ID: 29421431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pathogenicity of immunodominant T and B cell determinants of the nicotinic acetylcholine receptor epsilon-chain.
    Gaertner S; de Graaf KL; Wienhold W; Wiesmüller KH; Melms A; Weissert R
    J Neuroimmunol; 2004 Jul; 152(1-2):44-56. PubMed ID: 15223236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis.
    Adikari SB; Lian H; Link H; Huang YM; Xiao BG
    Clin Exp Immunol; 2004 Nov; 138(2):230-6. PubMed ID: 15498031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X; Zhao J; Kong Q; Xie X; Wang J; Sun B; Xu L; Mu L; Li H
    Immunol Invest; 2018 Oct; 47(7):712-724. PubMed ID: 29944018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental autoimmune myasthenia gravis in the mouse.
    Wu B; Goluszko E; Huda R; Tüzün E; Christadoss P
    Curr Protoc Immunol; 2011 Nov; Chapter 15():Unit 15.23. PubMed ID: 22048803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of Torpedo acetylcholine receptor in the context of different rat MHC class II haplotypes and non-MHC genomes.
    Gaertner S; de Graaf KL; Olsson T; Weissert R
    Immunogenetics; 2004 Apr; 56(1):61-4. PubMed ID: 15004728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental autoimmune myasthenia gravis in the mouse.
    Wu B; Goluszko E; Christadoss P
    Curr Protoc Immunol; 2001 May; Chapter 15():Unit 15.8. PubMed ID: 18432738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis.
    Feferman T; Maiti PK; Berrih-Aknin S; Bismuth J; Bidault J; Fuchs S; Souroujon MC
    J Immunol; 2005 May; 174(9):5324-31. PubMed ID: 15843529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.
    Wang HB; Shi FD; Li H; van der Meide PH; Ljunggren HG; Link H
    Clin Immunol; 2000 May; 95(2):156-62. PubMed ID: 10779409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.
    Tüzün E; Allman W; Ulusoy C; Yang H; Christadoss P
    Ann N Y Acad Sci; 2012 Dec; 1274():133-9. PubMed ID: 23252908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.